Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Sep 29;14(19):4758.
doi: 10.3390/cancers14194758.

Bacteriocins as Potential Therapeutic Approaches in the Treatment of Various Cancers: A Review of In Vitro Studies

Arnold Marshall Molujin  1 , Sahar Abbasiliasi  2 , Armania Nurdin  3 , Ping-Chin Lee  1   4 , Jualang Azlan Gansau  1 , Roslina Jawan  1
Affiliations
Review

Bacteriocins as Potential Therapeutic Approaches in the Treatment of Various Cancers: A Review of In Vitro Studies

Arnold Marshall Molujin et al. Cancers (Basel). .

Abstract

Cancer is regarded as one of the most common and leading causes of death. Despite the availability of conventional treatments against cancer cells, current treatments are not the optimal treatment for cancer as they possess the possibility of causing various unwanted side effects to the body. As a result, this prompts a search for an alternative treatment without exhibiting any additional side effects. One of the promising novel therapeutic candidates against cancer is an antimicrobial peptide produced by bacteria called bacteriocin. It is a non-toxic peptide that is reported to exhibit potency against cancer cell lines. Experimental studies have outlined the therapeutic potential of bacteriocin against various cancer cell lines. In this review article, the paper focuses on the various bacteriocins and their cytotoxic effects, mode of action and efficacies as therapeutic agents against various cancer cell lines.

Keywords: anticancer; bacteriocin; cancer; lactic acid bacteria; new treatment.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Mechanism of action of different bacteriocins on cancer cells.
See this image and copyright information in PMC

References

    1. Sung H., Ferlay J., Siegel R., Laversanne M., Soerjomataram I., Jemal A., Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2021;71:209–249. doi: 10.3322/caac.21660. - DOI - PubMed
    1. Norouzi Z., Salimi A., Halabian R., Fahimi H. Nisin, a potent bacteriocin and anti-bacterial peptide, attenuates expression of metastatic genes in colorectal cancer cell lines. Microb. Pathog. 2018;123:183–189. doi: 10.1016/j.micpath.2018.07.006. - DOI - PubMed
    1. Fathizadeh H., Saffari M., Esmaeili D., Moniri R., Mahabadi J.A. Anticancer effect of Enterocin A-Colicin E1 fusion peptide on gastric cancer cell. Probiotics Antimicrob. Proteins. 2021;13:1443–1451. doi: 10.1007/s12602-021-09770-y. - DOI - PubMed
    1. Taherikalani M., Ghafourian S. Anticancer properties of colicin E7 against colon cancer. Gastroenterol. Rev. 2021;16:364–368. doi: 10.5114/pg.2021.109622. - DOI - PMC - PubMed
    1. Ahmed N., Dawson M., Smith C., Wood E. Biology of Disease. Taylor & Francis Group; New York, NY, USA: 2017.